vialaudit
CAGRILINTIDE·OHIO·LAST CHECKED 1 NOV 2026

Is Cagrilintide legal in Ohio?

CAVEATS APPLY

Ohio's Board of Pharmacy names cagrilintide among the research-use-only drugs its inspectors find in clinics and says such drugs are unlawful for prescriber clinics and med spas to possess. Federally: Not as a drug. Cagrilintide has no FDA approval, so selling it for human use breaks federal drug law, and a 'research use only' label does not protect a seller whose site signals human use. It is not a controlled substance, and possessing it is not a federal crime. Pharmacies cannot compound it.

CATEGORY · INVESTIGATIONAL

Full status breakdown

FEDERAL · STATE · SPORT-BODY

Federal status

FDA approval
investigational
Indications: obesity (monotherapy + CagriSema combo); T2DM
DEA scheduling
not scheduled
503A compounding
FDA interim category: Not in any FDA category
503A Bulks List: not on list
Not eligible: no FDA approval (Novo Nordisk's CagriSema application is pending), no monograph, not on the 503A Bulks List. Ohio's Board of Pharmacy names it as a research-use-only drug found in clinics.
FDA Warning Letters
  • Dec 10, 2024 — Summit Research Peptides (cited: cagrilintide) · LETTER ↗
  • Dec 10, 2024 — Xcel Research LLC (cited: cagrilintide, semaglutide) · LETTER ↗
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: FDA has rejected RUO defense for cagrilintide in 2024 warning letters (Xcel, Summit). Same posture as retatrutide.
Personal possession: Not federally scheduled; not criminally possessed at federal level. Enforcement is on sellers.

Ohio — state-specific

pharmacy board enforcement · Ohio

Ohio's Board of Pharmacy names cagrilintide among the research-use-only drugs its inspectors find in clinics and says such drugs are unlawful for prescriber clinics and med spas to possess.

Sport-body status

WADA 2026
prohibited · class S0 · in and out of competition
Not named. With no government approval yet, it falls under S0. That would change if CagriSema is approved. WADA's 2027 List, in force from 1 Jan 2027, now names 'peptides' among the S0 examples; the status does not change.
USADA
NCAA
unknown

What we couldn’t verify

Also known as

3 ALIASES

Cagrilintide is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • amylin analogue
  • CagriSema
  • CagriLean

Related

FOLLOW-ONS

Cagrilintide: US status, sources and what changed

THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH